Alopecia Totalis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Clinical Trials

Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
Conditions:   Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis Interventions:   Drug: BNZ-1;   Drug: Normal saline Sponsor:   Bioniz Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2018 Category: Research Source Type: clinical trials